There is still a lot of stigma surrounding the use of magical mushrooms. After all, ‘shrooms’ as they are popularly called, are one of the representatives of the excess that was the counterculture of the 1960s. This stigma intensified when the use of psychedelic drugs, including the molecule psilocybin, was banned through the 1971 UN Convention on Psychotropic Substances.
Fortunately, it only takes a few searches on the Internet to know just how extensive, and well-supported the medical research on the substance has come since the first psilocybin study at The University of Zurich.
As your leading provider of magic mushrooms in Calgary, Alberta, we at Blue Buddha Canada, are just excited as you are with these advancements in psilocybin use. Here are what the current research and clinical studies have to say about its potential medicinal use:
- As treatment for depression, anxiety, and other psychological conditions
In the US, the substance psilocybin has been designated a ‘breakthrough therapy’ status by the FDA, indicating its potential to be a better alternative than the ones already in the market.
- As treatment for chronic pain from cluster headaches and neuralgia, among others
Much like the effects of the cannabinoids from premium cannabis have on relieving chronic pain, the psilocybin from magic mushrooms have shown to have the ability to provide relief. Separate studies from the Journal of Psychoactive Drugs (2015), Neurology (2006), and Neurocase (2018) all show relief from cluster attacks and improvement in intractable phantom pain, respectively.
- As a relief from the psychological distress from cancer and other end-of-life conditions
‘Existential distress’ or the feeling of despair from the thought of life having no meaning is a common reported psychiatric disorder among cancer patients after undergoing treatment. However, the available anti-depressants in the market are not always effective in providing relief. But a study published in the Journal of Psychopharmacology reported the ability of a single dose of synthetic psilocybin to reverse the distress on a long-term basis.
Relief from distress from about 60% to 80% of cancer patients; respectively, were also reported from two other separate studies from New York University (NYU) Langone Medical Center in New York City and Johns Hopkins Medical School in Baltimore.
- As treatment for addiction cessation, especially from alcohol and nicotine
Psilocybin hits the primary brain receptor serotonin 2A, decreasing the activity in the parts of the brain that are overactive in addiction and ingrained behaviors and thus deactivating cravings.
Upcoming studies of psilocybin as a potential therapy for opioid addiction, Alzheimer’s disease, and post-traumatic stress disorder (PTSD) are reportedly underway at John Hopkins.
You can’t expect the psilocybin in your magic mushroom strains in Alberta to have the same effects as those of the study since testing was done in a controlled clinical setting, but you can still enjoy premium quality mail order magic mushrooms when you order from us. Place yours today!